N/A
N=165
Tourniquet on Total Knee Arthroplasty
Arthritis Knee
Bottom Line
View on ClinicalTrials.gov: NCT04923724 ↗Enrolled (actual)
165
Serious AEs
0.9%
Results posted
May 2025
Primary outcome: Primary: Pain After TKA Measured by VAS Pain Survey on Focusmotion App — 2.8; 2.6 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- tourniquet (Device); No tourniquet (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Washington University School of Medicine
- Primary completion
- Nov 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pain After TKA Measured by VAS Pain Survey on Focusmotion App |
2.8; 2.6 | — |
| SECONDARY Functional Recovery Measured by Oxford Knee Score Scale |
43.0; 41.37 | — |
| SECONDARY Functional Recovery Measured by Forgotten Joint Score |
68.4; 70.9 | — |
| SECONDARY Functional Recovery Measured by Normal Knee Survey |
79.3; 81.5 | — |
Summary
The purpose of this study is determine the effect on novel pressure-regulating tourniquet use on pain, functional recovery, sleep and total blood loss following total knee arthroplasty.
Eligibility Criteria
Inclusion Criteria
- Age 18 and up
- Primary unilateral TKA
- BMI 5days/week
- History of unprovoked VTE/PE
- Inability to complete baseline functional testing
Data sourced from ClinicalTrials.gov (NCT04923724). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.